期刊文献+

2011年风湿免疫病主要临床新进展 被引量:3

下载PDF
导出
摘要 时光荏苒,2011年国际风云变幻莫测,科学进展令人惊叹,看似平淡的风湿病学也蕴藏着丰富的新进展。2010年纷纷出台的新诊断标准在2011年被广泛应用和验证,治疗目标和措施也在不断调整,变迁日新月异。
出处 《临床荟萃》 CAS 2012年第6期469-473,共5页 Clinical Focus
  • 相关文献

参考文献25

  • 1Weber U,Ostergaard M,Lambert RG,et al.The impact ofMRI on the clinical management of inflammatory arthritides[J].Skeletal Radiology,2011,40(9):1153-1173.
  • 2Hyrich KL,Watson KD,Lunt M,et al.Changes in diseasecharacteristics and response rates among patients in the UnitedKingdom starting anti-tumour necrosis factor therapy forrheumatoid arthritis between 2001and 2008[J].Rheumatology(Oxford),2011,50(1):117-23.
  • 3Rahman MU,Buchanan J,Doyle MK,et al.Changes in patientcharacteristics in anti-tumour necrosis factor clinical trials forrheumatoid arthritis:results of an analysis of the literatureover the past 16years[J].Ann Rheum Dis,2011,70(9):1631-1640.
  • 4Hammer HB,Kvien TK.Ultrasonography shows significantimprovement in wrist and ankle tenosynovitis in rheumatoidarthritis patients treated with adalimumab[J].Scand JRheumatol,2011,40(3):178-182.
  • 5Staples MP,March L,Lassere M,et al.Health-related qualityof life and continuation rate on first-line anti-tumour necrosisfactor therapy among rheumatoid arthritis patients from theAustralian Rheumatology Association Database[J].Rheumatology(Oxford),2011,50(1):166-175.
  • 6Chatzidionysiou K,Lie E,Nasonov E,et al.Highest clinicaleffectiveness of rituximab in autoantibody-positive patientswith rheumatoid arthritis and in those for whom no more thanone previous TNF antagonist has failed:pooled data from 10European registries[J].Ann Rheum Dis,2011,70(9):1575-1580.
  • 7Galloway JB,Hyrich KL,Mercer LK,et al.Risk of septicarthritis in patients with rheumatoid arthritis and the effect ofanti-TNF therapy:results from the British Society forRheumatology Biologics Register[J].Ann Rheum Dis,2011,70(10):1810-1814.
  • 8Lan JL,Chen YM,Hsieh TY,et al.Kinetics of viral loads andrisk of hepatitis B virus reactivation in hepatitis B coreantibody-positive rheumatoid arthritis patients undergoinganti-tumour necrosis factor alpha therapy[J].Ann RheumDis,2011,70(10):1719-1725.
  • 9Agarwal SK.Biologic agents in rheumatoid arthritis:an updatefor managed care professionals[J].J Manag Care Pharm,2011,17(9Suppl B):14-18.
  • 10Wong AK,Kerkoutian S,Said J,et al.Risk of lymphoma inpatients receiving antitumor necrosis factor therapy:a meta-analysis of published randomized controlled studies[J].ClinRheumatol,2011,18. [Epub ahead of print].

同被引文献19

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部